To improve the prognosis of patients with cancer, an increasing number of studies have identified biomarkers that can predict cancer prognosis through bioinformatics analysis, such as Zhao et al. who found that aberrant expression of STEAP1 in pancancer predicted survival and CFS and could be a potential therapeutic target [50]. Here, STEAP1 is linked to cancer.